Who Paid My Doc
Precisetumor
Device Oncology
General payments
$318,210
Research payments
$2,663,602
Through program year 2025, $318,210 in general payments and $2,663,602 in research payments were reported against Precisetumor (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,676 | 135 |
| 2025 | Research | $2,416,112 | 94 |
| 2024 | General | $146,294 | 588 |
| 2024 | Research | $200,096 | 45 |
| 2023 | General | $167,239 | 1,358 |
| 2023 | Research | $47,394 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,081 general · 147 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.